Philips (NYSE:PHG) aligned itself with Israel-based medical device company P-Cure, in order to advance the smaller firm’s proton therapy technology.
Radiosurgery/Radiation therapy
ViewRay aims global with new $30M in funding for MRI-guided radiation therapy
Ohio-based ViewRay Inc. is looked to widen its global commercial reach with new funds raised from both new and existing investors.
ViewRay touted $30 million in new funding that the privately held company plans to use to market its ViewRay MRI-guided radiation therapy system around the world.
Varian Medical OKs $6M share buyback for 2014
Palo Alto, Calif.-based Varian Medical (NYSE:VAR) announced today the authorization of a $6 million common stock buyback program, authorized by its board of directors.
Accuray gains on Q1 results
Accuray (NSDQ:ARAY) shares gained nearly 10% this morning after the medical device company reported lower fiscal 1st-quarter losses and an improved profit margin.
Sunnyvale, Calif.-based Accuray logged losses of $15.5 million, or -21¢ per share, on sales of $76.6 million for the 3 months ended Sept. 30, for a loss reduction of 35.6% on a sales decline of 7.4%.
Breast cancer: Hologic touts ‘excellent’ results from 7-year MammoSite registry
Elekta lands $25M Gamma Knife order from China
Varian sells 20 new radiosurgery systems to U.K. healthcare regulators
The British NHS Supply Chain bought 20 of Varian Medical Systems‘ (NYSE:VAR) TrueBeam devices as part of a planned upgrade of radiotherapy and radiosurgery systems in the nation’s hospitals.
Accuray touts another quarter of growth, gains Wall Street favor
Elekta, Varian settle trade theft, rep-poaching lawsuit
Varian struggles in Japan in Q3, adjusts full-year guidance
Varian Medical Systems (NYSE:VAR) got a little Wall Street love today, despite reporting significant Q3 headwinds that spurred an adjustment of the company’s full-year guidance.